Your browser doesn't support javascript.
loading
Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting.
Burger, Gerrit; Adamou, Rafiou; Kreuzmair, Ruth; Ndoumba, Wilfrid Ndzebe; Mbassi, Dorothea Ekoka; Mouima, Anne Marie Nkoma; Tabopda, Carole Mamgno; Adegnika, Roukoyath Moyoriola; More, Ayong; Okwu, Dearie Glory; Mbadinga, Lia-Betty Dimessa; Calle, Carlos Lamsfus; Veletzky, Luzia; Metzger, Wolfram Gottfried; Mordmüller, Benjamin; Ramharter, Michael; Mombo-Ngoma, Ghyslain; Adegnika, Ayola Akim; Zoleko-Manego, Rella; McCall, Matthew B B.
Afiliação
  • Burger G; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Adamou R; Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
  • Kreuzmair R; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Ndoumba WN; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Mbassi DE; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Mouima AMN; Department of Implementation Research, Bernhard Nocht Institute for Tropical Medicine & I Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tabopda CM; German Center for Infection Research, Partner sites Hamburg-Borstel-Lübeck-Riems, Germany.
  • Adegnika RM; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • More A; German Center for Infection Research, Partner sites Hamburg-Borstel-Lübeck-Riems, Germany.
  • Okwu DG; Centre for Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Mbadinga LD; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Calle CL; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Veletzky L; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Metzger WG; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Mordmüller B; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Ramharter M; Department of Implementation Research, Bernhard Nocht Institute for Tropical Medicine & I Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Mombo-Ngoma G; German Center for Infection Research, Partner sites Hamburg-Borstel-Lübeck-Riems, Germany.
  • Adegnika AA; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Zoleko-Manego R; Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
  • McCall MBB; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
PLoS Negl Trop Dis ; 18(5): e0012203, 2024 May.
Article em En | MEDLINE | ID: mdl-38771861
ABSTRACT

BACKGROUND:

Chronic infection by Loa loa remains an unsolved immunological paradox. Despite harboring subcutaneously migrating adult worms and often high densities of microfilariae, most patients experience only relatively mild symptoms, yet microfilaricidal treatment can trigger life-threatening inflammation. Here, we investigated innate cell populations hypothesized to play a role in these two faces of the disease, in an endemic population in Gabon. METHODOLOGY/PRINCIPAL

FINDINGS:

We analyzed numbers and activation of eosinophils and basophils, as well as myeloid-derived suppressor cell (MDSC) subsets and associated circulating cytokine levels by flow cytometry in sex- and age-matched L. loa-uninfected (LL-), -amicrofilaraemic (MF-) and -microfilaraemic (MF+) individuals (n = 42), as well as microfilaraemic individuals treated with albendazole (n = 26). The percentage of eosinophils was lower in LL- (3.0%) than in the combined L. loa-infected population, but was similar in MF+ (13.1%) and MF- (12.3%). Upon treatment of MF+, eosinophilia increased from day 0 (17.2%) to day 14 (24.8%) and had decreased below baseline at day 168 (6.3%). Expression of the eosinophil activation marker CD123 followed the same pattern as the percentage of eosinophils, while the inverse was observed for CD193 and to some extent CD125. Circulating IL-5 levels after treatment followed the same pattern as eosinophil dynamics. Basophil numbers did not differ between infection states but increased after treatment of MF+. We did not observe differences in MDSC numbers between infection states or upon treatment. CONCLUSIONS/

SIGNIFICANCE:

We demonstrate that both chronic infection and treatment of L. loa microfilaraemia are associated with eosinophil circulation and distinct phenotypical activation markers that might contribute to inflammatory pathways in this setting. In this first ever investigation into MDSC in L. loa infection, we found no evidence for their increased presence in chronic loiasis, suggesting that immunomodulation by L. loa is induced through other pathways.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Basófilos / Loíase / Eosinófilos / Células Supressoras Mieloides / Loa Limite: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: PLoS Negl Trop Dis Assunto da revista: MEDICINA TROPICAL Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Gabão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Basófilos / Loíase / Eosinófilos / Células Supressoras Mieloides / Loa Limite: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: PLoS Negl Trop Dis Assunto da revista: MEDICINA TROPICAL Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Gabão